Vault-13

First Turn Management, LLC

DEL MAR, CA · CIK 1993440 · 13F filing filed 2026-08-14

SEC-registered investment adviser since 2023 · limited liability company

$934.7m reported value +4.4% vs Q1 2026
31positions
53.6%in top 10
6 new 13 added 11 reduced 8 sold out vs Q1 2026

Holdings, Q2 2026

The small lines show how much was held over the last 4 quarters (adjusted for stock splits).

#SecurityTickerShares Value% of portfolioChangeShares change
1 REVOLUTION MEDICINES INC COM RVMD RVMD 415,307 $77.8m8.32% 8.32% ReducedShares held: Q3 2025 643.0k, Q4 2025 638.4k, Q1 2026 468.4k, Q2 2026 415.3k -53.1k -53,069 -11.3%
2 ABIVAX SA SPONSORED ADS ABVX ABVX 489,889 $65.3m6.98% 6.98% AddedShares held: Q3 2025 291.8k, Q4 2025 381.2k, Q1 2026 465.9k, Q2 2026 489.9k +24.0k +24,020 5.2%
3 AXSOME THERAPEUTICS INC COM AXSM AXSM 218,415 $53.5m5.72% 5.72% AddedShares held: Q3 2025 152.6k, Q4 2025 206.9k, Q1 2026 188.8k, Q2 2026 218.4k +29.6k +29,643 15.7%
4 ENLIVEN THERAPEUTICS INC COM ELVN ELVN 954,360 $48.4m5.18% 5.18% AddedShares held: Q3 2025 783.4k, Q4 2025 0, Q1 2026 623.8k, Q2 2026 954.4k +330.5k +330,521 53.0%
5 BRIDGEBIO PHARMA INC COM BBIO BBIO 633,364 $47.2m5.05% 5.05% ReducedShares held: Q3 2025 589.7k, Q4 2025 595.5k, Q1 2026 695.7k, Q2 2026 633.4k -62.4k -62,354 -9.0%
6 ROIVANT SCIENCES LTD SHS ROIV ROIV 1,331,066 $47.1m5.04% 5.04% AddedShares held: Q3 2025 959.7k, Q4 2025 1.2m, Q1 2026 1.2m, Q2 2026 1.3m +140.9k +140,948 11.8%
7 UNITED THERAPEUTICS CORP DEL COM UTHR UTHR 84,932 $46.0m4.92% 4.92% ReducedShares held: Q3 2025 85.3k, Q4 2025 63.6k, Q1 2026 104.7k, Q2 2026 84.9k -19.8k -19,794 -18.9%
8 CYTOKINETICS INC COM NEW CYTK CYTK 527,412 $44.9m4.81% 4.81% AddedShares held: Q3 2025 254.8k, Q4 2025 325.7k, Q1 2026 283.7k, Q2 2026 527.4k +243.7k +243,712 85.9%
9 XENON PHARMACEUTICALS INC COM XENE XENE 600,200 $36.2m3.88% 3.88% ReducedShares held: Q3 2025 799.7k, Q4 2025 799.7k, Q1 2026 786.8k, Q2 2026 600.2k -186.6k -186,644 -23.7%
10 CELCUITY INC COM CELC CELC 329,101 $34.4m3.68% 3.68% AddedShares held: Q3 2025 0, Q4 2025 0, Q1 2026 210.6k, Q2 2026 329.1k +118.5k +118,523 56.3%
11 VIRIDIAN THERAPEUTICS INC COM VRDN VRDN 1,670,000 $30.7m3.28% 3.28% AddedShares held: Q3 2025 0, Q4 2025 690.5k, Q1 2026 911.3k, Q2 2026 1.7m +758.7k +758,663 83.2%
12 INSMED INC COM PAR $.01 INSM INSM 263,851 $28.1m3.01% 3.01% AddedShares held: Q3 2025 319.8k, Q4 2025 264.3k, Q1 2026 248.5k, Q2 2026 263.9k +15.4k +15,376 6.2%
13 UNIQURE NV SHS QURE QURE 608,925 $28.0m3.00% 3.00% ReducedShares held: Q3 2025 0, Q4 2025 321.7k, Q1 2026 615.5k, Q2 2026 608.9k -6.6k -6,564 -1.1%
14 ASCENDIS PHARMA A/S ORD SHS ASND ASND 104,877 $28.0m2.99% 2.99% NewShares held: Q3 2025 0, Q4 2025 0, Q1 2026 0, Q2 2026 104.9k
15 PRAXIS PRECISION MEDICINES I COM NEW PRAX PRAX 83,528 $28.0m2.99% 2.99% AddedShares held: Q3 2025 0, Q4 2025 35.7k, Q1 2026 42.4k, Q2 2026 83.5k +41.1k +41,087 96.8%
16 DIANTHUS THERAPEUTICS INC COM DNTH DNTH 285,771 $27.9m2.98% 2.98% AddedShares held: Q3 2025 0, Q4 2025 0, Q1 2026 220.9k, Q2 2026 285.8k +64.8k +64,850 29.4%
17 VAXCYTE INC COM PCVX PCVX 443,836 $25.8m2.76% 2.76% NewShares held: Q3 2025 0, Q4 2025 0, Q1 2026 0, Q2 2026 443.8k
18 MIRUM PHARMACEUTICALS INC COM MIRM MIRM 218,051 $25.5m2.73% 2.73% ReducedShares held: Q3 2025 570.6k, Q4 2025 481.6k, Q1 2026 400.5k, Q2 2026 218.1k -182.4k -182,413 -45.5%
19 PALVELLA THERAPEUTICS INC NE COM PVLA PVLA 156,450 $23.9m2.56% 2.56% AddedShares held: Q3 2025 0, Q4 2025 0, Q1 2026 148.1k, Q2 2026 156.4k +8.4k +8,357 5.6%
20 COGENT BIOSCIENCES INC COM COGT COGT 602,281 $23.3m2.49% 2.49% ReducedShares held: Q3 2025 0, Q4 2025 824.3k, Q1 2026 947.3k, Q2 2026 602.3k -345.1k -345,058 -36.4%
21 ERASCA INC COM ERAS ERAS 1,221,721 $22.4m2.39% 2.39% AddedShares held: Q3 2025 0, Q4 2025 0, Q1 2026 867.6k, Q2 2026 1.2m +354.1k +354,082 40.8%
22 ORIC PHARMACEUTICALS INC COM ORIC ORIC 2,017,284 $21.8m2.34% 2.34% UnchangedShares held: Q3 2025 2.2m, Q4 2025 2.0m, Q1 2026 2.0m, Q2 2026 2.0m
23 NEWAMSTERDAM PHARMA COMPANY ORDINARY SHARES NAMS NAMS 582,497 $19.7m2.11% 2.11% AddedShares held: Q3 2025 717.0k, Q4 2025 893.5k, Q1 2026 558.3k, Q2 2026 582.5k +24.2k +24,161 4.3%
24 APOGEE THERAPEUTICS INC COM COM 138,822 $18.4m1.97% 1.97% ReducedShares held: Q3 2025 402.8k, Q4 2025 474.8k, Q1 2026 513.8k, Q2 2026 138.8k -374.9k -374,948 -73.0%
25 RHYTHM PHARMACEUTICALS INC COM RYTM RYTM 154,018 $17.1m1.83% 1.83% NewShares held: Q3 2025 0, Q4 2025 146.3k, Q1 2026 0, Q2 2026 154.0k
26 INHIBRX BIOSCIENCES INC COM INBX INBX 164,783 $15.6m1.67% 1.67% NewShares held: Q3 2025 0, Q4 2025 0, Q1 2026 0, Q2 2026 164.8k
27 SCHOLAR ROCK HLDG CORP COM SRRK SRRK 271,227 $14.9m1.60% 1.60% ReducedShares held: Q3 2025 0, Q4 2025 459.7k, Q1 2026 446.4k, Q2 2026 271.2k -175.2k -175,163 -39.2%
28 ORUKA THERAPEUTICS INC COM ORKA ORKA 155,343 $14.8m1.58% 1.58% NewShares held: Q3 2025 0, Q4 2025 0, Q1 2026 0, Q2 2026 155.3k
29 KYMERA THERAPEUTICS INC COM KYMR KYMR 102,533 $11.8m1.26% 1.26% ReducedShares held: Q3 2025 277.7k, Q4 2025 206.4k, Q1 2026 254.7k, Q2 2026 102.5k -152.1k -152,139 -59.7%
30 SIONNA THERAPEUTICS INC COM SION SION 110,493 $4.9m0.52% 0.52% NewShares held: Q3 2025 0, Q4 2025 0, Q1 2026 0, Q2 2026 110.5k
31 NUVALENT INC COM COM 26,298 $3.2m0.35% 0.35% ReducedShares held: Q3 2025 394.8k, Q4 2025 368.7k, Q1 2026 370.3k, Q2 2026 26.3k -344.0k -344,046 -92.9%

Sold out since Q1 2026

SecurityTickerShares held beforeValue then
IDEAYA BIOSCIENCES INC IDYA IDYA 873,838 $29.1m873.8k shares
ASCENDIS PHARMA A/S 76,300 $17.5m76.3k shares
FULCRUM THERAPEUTICS INC FULC FULC 2,256,109 $17.3m2.3m shares
TERNS PHARMACEUTICALS INC 326,694 $17.2m326.7k shares
VERA THERAPEUTICS INC VERA VERA 422,023 $17.0m422.0k shares
NATERA INC NTRA NTRA 81,077 $16.2m81.1k shares
OLEMA PHARMACEUTICALS INC OLMA OLMA 768,662 $11.5m768.7k shares
MOONLAKE IMMUNOTHERAPEUTICS MLTX MLTX 315,563 $5.9m315.6k shares